Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factor-kappa B, and apoptosis

Bibliographic Information
Authors: El-Din S.H.S.; El-Lakkany N.M.; Salem M.B.; Hammam O.A.; Saleh S.; Botros S.S.
Journal: Journal of Advanced Pharmaceutical Technology and Research
Publisher: Wolters Kluwer Medknow Publications
Publication Date: 2016
Volume / Issue: Volume 7 / Issue 3
Pages: 99–104
ISSN: 22314040
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
El-Din S.H.S., Department of Pharmacology, Theodor Bilharz Research Institute, Warak El-Hadar, P.O. Box: 30, Imbaba, Giza, 12411, Egypt; El-Lakkany N.M., Department of Pharmacology, Theodor Bilharz Research Institute, Warak El-Hadar, P.O. Box: 30, Imbaba, Giza, 12411, Egypt; Salem M.B., Department of Pharmacology, Theodor Bilharz Research Institute, Warak El-Hadar, P.O. Box: 30, Imbaba, Giza, 12411, Egypt; Hammam O.A., Department of Pathology, Theodor Bilharz Research Institute, Warak El-Hadar, Imbaba, Giza, 12411, Egypt; Saleh S., Department of Pharmacology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt; Botros S.S., Department of Pharmacology, Theodor Bilharz Research Institute, Warak El-Hadar, P.O. Box: 30, Imbaba, Giza, 12411, Egypt
Abstract
Resveratrol is a naturally occurring polyphenol, possesses several pharmacological activities including anticancer, antioxidant, antidiabetic, antinociceptive, and antiasthmatic activity. Little is known about its hepatoprotective action mechanisms. This study was conceived to explore the possible protective mechanisms of resveratrol compared with the hepatoprotective silymarin in thioacetamide (TAA)-induced hepatic injury in rats. Thirty-two rats were equally divided into four groups; normal control (i), TAA (100 mg/kg) (ii), TAA + silymarin (50 mg/kg) (iii), and TAA + resveratrol (10 mg/kg) (iv). Liver function and histopathology, pro-inflammatory cytokines, oxidative stress, and apoptotic markers were examined. Data were analyzed using ANOVA test followed by Tukey post hoc test. Compared to TAA-intoxicated group, resveratrol mitigated liver damage, and inflammation as noted by less inflammatory infiltration, hydropic degeneration with decreased levels of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma by 78.83, 18.12, and 64.49%, respectively. Furthermore, it reduced (P < 0.05) alanine and aspartate aminotransferases by 36.64 and 48.09%, respectively, restored hepatic glutathione content and normalized superoxide dismutase and malondialdehyde levels. While it inhibited nuclear factor-kappa B, cytochrome 2E1, and enhanced apoptosis of necrotic hepatocytes via increasing caspase-3 activity. Our findings indicated that the potential hepatoprotective mechanisms of resveratrol are associated with inhibition of inflammation, enhancing the apoptosis of necrotic hepatocytes, and suppression of oxidative stress. © 2016 Journal of Advanced Pharmaceutical Technology & Research | Published by Wolters Kluwer - Medknow.
Keywords
Caspase-3; Cytotoxicity; Liver inflammation; Pro-inflammatory cytokines; Resveratrol; alanine aminotransferase; aspartate aminotransferase; caspase 3; cytochrome P450 2E1; gamma interferon; glutathione; immunoglobulin enhancer binding protein; interleukin 6; malonaldehyde; silymarin; superoxide dismutase; tumor necrosis factor alpha; animal cell; animal experiment; animal model; animal tissue; antiinflammatory activity; antioxidant activity; apoptosis; Article; controlled study; drug mechanism; enzyme activity; histopathology; in vitro study; liver cell; liver function; liver injury; liver protection; nonhuman; outcome assessment; oxidative stress; priority journal; rat
Citation Information
Scopus Citations: 24
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
